Investment Summary

Exits Kite Pharma

On June 20, 2014, invested in life science company Kite Pharma from Alta Partners

Investment Highlights
  • This is transaction in the Life Science sector.
  • This is transaction in the United States.
  • This is transaction in California.
Investment Fate
  • Kite Pharma was sold to a strategic buyer in 2017 for 11.9B USD.

Investment Summary
Date 2014-06-20
Target Kite Pharma
Sector Life Science
Sellers(s) Alta Partners
Deal Type IPO

Target

Kite Pharma

Santa Monica, California, United States
Kite Pharma's corporate headquarters in Santa Monica, California.
Kite Pharma's corporate headquarters in Santa Monica, California.
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on eACT designed to restore the immune system's ability to recognize and eradicate tumors. Kite Pharma was formed in 2009 and is based in Santa Monica, California.

Search 200,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Seller(S) 1

SELLER

Alta Partners

Jackson, Wyoming, United States

Investor Investor Investor Investor

Category Venture Capital Firm
Founded 1996
PE ASSETS 2.6B USD
Size Large
Type Sector Focused
DESCRIPTION

Alta Partners is a venture capital firm that targets investments in early and later stage life science companies, including biopharmaceuticals, medical technology, and information technology businesses. Alta was formed as an early stage investor but has since expanded its investment range to provide later stage growth capital to private and young public companies. Alta was established in 1996 and is headquartered in San Francisco, California.

DEAL STATS #
Overall 72 of 84
Sector (Life Science) 55 of 64
Type (IPO) 27 of 32
State (California) 34 of 41
Country (United States) 64 of 74
Year (2014) 8 of 10
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-18 Zafgen

Boston, Massachusetts, United States

Zafgen is a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders. Zafgen was founded in 2005 and is based in Boston, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-07-24 Immune Design

Seattle, Washington, United States

Immune Design Corp. is a biotechnology company focused on developing a broad platform of novel vaccines (both therapeutic and prophylactic) for the treatment of infectious disease. The Company's technologies regulate immunity by targeting dendritic cell responses with combinations of proprietary viral vectors, TLR agonists, and adjuvants. Immune Design was founded in 2008 and is based in Seattle, Washington.

Sell -
Mergr

Product

Company

Legal